GSA Capital Partners »

Cartesian Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $880k 86k 10.22
2025-06-30 $432k 42k 10.38
2025-03-31 $221k 17k 13.16